Our teams have a constant eye on the horizon to ensure we’re not only providing cutting-edge solutions to meet consumer and market demand, but that as we do so, we’re continuing to make food extraordinary.
Tate & Lyle Ventures announces today that it will invest in UK-based marine biotechnology company, Aquapharm Biodiscovery Ltd (Aquapharm). Tate & Lyle Ventures forms part of a consortium which has invested second round funding of £4.0m. Aquapharm…